Common StockUnderwriting Agreement • November 13th, 2000 • Medequity Investors LLC • Services-commercial physical & biological research
This letter is being delivered to you in connection with the proposed Underwriting Agreement (the "Underwriting Agreement") to be entered into by and among MediChem Life Sciences, Inc., a Delaware corporation (the "Company"), and you, as representatives of the several underwriters, with respect to the initial public offering ("Initial Public Offering") of Common Stock, $0.01 par value per share (the "Common Stock"), of the Company.
